Effect of aging on the vascular system plus monitoring and support

Surgical Clinics of North America

Volumn 95, Issue 1, 2015, Pages 37-51

  Villella, Ed ^a   Cho, Jae S ^b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Aging; Arterial stiffness; Atherosclerosis; Endothelial progenitor cells; Nitric oxide; Oxidative stress

Indexed keywords

ARGININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; NITRIC OXIDE; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SIRTUIN; SOMATOMEDIN;

AGING; ANATOMICAL VARIATION; ANDROGEN THERAPY; ARTERY ENDOTHELIUM; CALORIC RESTRICTION; CARDIOVASCULAR SYSTEM; DIET; ENDOTHELIAL PROGENITOR CELL; ESTROGEN THERAPY; EXERCISE; HUMAN; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; RISK FACTOR; TELOMERE SHORTENING; AGE; AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR DISEASES; VASCULAR ENDOTHELIUM;

AGE FACTORS; AGED; AGING; ENDOTHELIUM, VASCULAR; HUMANS; RISK FACTORS; VASCULAR DISEASES;

EID: 84912116192     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2014.09.007     Document Type: Review

References (58)

1. Gragasin F.S., Bourque S.L., Davidge S.T. Vascular aging and hemodynamic stability in the intraoperative period. Front Physiol 2012, 3:31-37.
2. Ferrari A.U., Radaelli A., Centola M. Invited review: aging and the cardiovascular system. JAppl Physiol (1985) 2003, 95(6):2591-2597.
3. Cau S., Carneiro F.S. Differential modulation of nitric oxide synthases in aging: therapeutic opportunities. Front Physiol 2012, 3(218):1-11.
4. Mirea O., Donoiu I., Plesea I.E. Arterial aging: a brief review. Rom J Morphol Embryol 2012, 53(3):473-477.
5. Lekontseva O., Jiang Y., Schleppe C., et al. Altered neuronal nitric oxide synthase in the aging vascular system: implications for estrogens therapy. Endocrinology 2012, 153(8):3940-3948.
6. Fujiyama S., Amano K., Uehira K., et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 2003, 93(10):980-989.
7. Keymel S., Kalka C., Rassaf T., et al. Impaired endothelial progenitor cell function predicts age-dependent carotid intimal thickening. Basic Res Cardiol 2008, 103(6):582-586.
8. Virmani R., Avolio A.P., Mergner W.J., et al. Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. Am J Pathol 1991, 139(5):1119-1129.
9. Benetos A., Waeber B., Izzo J., et al. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 2002, 15(12):1101-1108.
10. Choi S.Y., Oh B.H., Bae P.J., et al. Age-associated increase in arterial stiffness measured according to the cardio-ankle vascular index without blood pressure changes in healthy adults. JAtheroscler Thromb 2013, 20(12):911-923.
11. Li Z., Froehlich J., Galis Z.S., et al. Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. Hypertension 1999, 33(1):116-123.
12. Franklin S.S., Gustin W., Wong N.D., et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997, 96(1):308-315.
13. Blacher J., Asmar R., Djane S., et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999, 33(5):1111-1117.
14. Blacher J., London G.M., Safar M.E., et al. Influence of age and end-stage renal disease on the stiffness of carotid wall material in hypertension. JHypertens 1999, 17(2):237-244.
15. Vallance P. Control of the human cardiovascular system by nitric oxide. JHum Hypertens 1996, 10(6):377-381.
16. Wilkinson I.B., Qasem A., McEniery C.M., et al. Nitric oxide regulates local arterial distensibility invivo. Circulation 2002, 105(2):213-217.
17. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288(27):373-376.
18. Moncada S., Radomski M.W., Palmer R.M. Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988, 37(13):2495-2501.
19. Melikian N., Seddon M.D., Casadei B., et al. Neuronal nitric oxide synthase and human vascular regulation. Trends Cardiovasc Med 2009, 19(8):256-262.
20. Villanueva C., Giulivi C. Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease. Free Radic Biol Med 2010, 49(3):307-316.
21. Hecker M., Cattaruzza M., Wagner A.H. Regulation of inducible nitric oxide synthase gene expression in vascular smooth muscle cells. Gen Pharmacol 1999, 32(1):9-16.
22. Blackwell K.A., Sorenson J.P., Richardson D.M., et al. Mechanisms of aging-induced impairment of endothelium-dependent relaxation: role of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol 2004, 287(6):H2448-H2453.
23. Delp M.D., Behnke B.J., Spier S.A., et al. Ageing diminishes endothelium-dependent vasodilatation and tetrahydrobiopterin content in rat skeletal muscle arterioles. JPhysiol 2008, 586(4):1161-1168.
24. Gerhard M., Roddy M.A., Creager S.J., et al. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996, 27(4):849-853.
25. Muller-Delp J.M., Spier S.A., Ramsey M.W., et al. Aging impairs endothelium-dependent vasodilation in rat skeletal muscle arterioles. Am J Physiol Heart Circ Physiol 2002, 283(4):H1662-H1672.
26. Rodriguez-Manas L., El-Assar M., Vallejo S., et al. Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation. Aging Cell 2009, 8(3):226-238.
27. Sun D., Huang A., Yan E.H., et al. Reduced release of nitric oxide to shear stress in mesenteric arteries of aged rats. Am J Physiol Heart Circ Physiol 2004, 286(6):H2249-H2256.
28. Taddei S., Virdis A., Ghiadoni L., et al. Age-related reduction of NO availability and oxidative stress in humans. Hypertension 2001, 38(2):274-279.
29. Ungvari Z., Csiszar A., Kaley G. Vascular inflammation in aging. Herz 2004, 29(8):733-740.
30. Briones A.M., Montoya N., Giraldo J., et al. Ageing affects nitric oxide synthase, cyclooxygenase and oxidative stress enzymes expression differently in mesenteric resistance arteries. Auton Autacoid Pharmacol 2005, 25(4):155-162.
31. Novensa L., Novella S., Medina P., et al. Aging negatively affects estrogens-mediated effects on nitric oxide bioavailability by shifting ERalpha/ERbeta balance in female mice. PLoS One 2011, 6(9):e25335.
32. El Assar M., Angulo J., Vallejo S., et al. Mechanisms involved in the aging-induced vascular dysfunction. Front Physiol 2012, 3(132):1-13.
33. Marin C., Yubero-Serrano E.M., Lopez-Miranda J., et al. Endothelial aging associated with oxidative stress can be modulated by a healthy Mediterranean diet. Int J Mol Sci 2013, 14(5):8869-8889.
34. Marin J., Rodriguez-Martinez M.A. Nitric oxide, oxygen-derived free radicals and vascular endothelium. JAuton Pharmacol 1995, 15(4):279-307. [review].
35. Bode-Boger S.M., Muke J., Surdacki A., et al. Oral L-arginine improves endothelial function in healthy individuals older than 70 years. Vasc Med 2003, 8(2):77-81.
36. Elliott H.L., Sumner D.J., McLean K., et al. Effect of age on the responsiveness of vascular alpha-adrenoceptors in man. JCardiovasc Pharmacol 1982, 4(3):388-392.
37. Lyons D., Roy S., Patel M., et al. Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age. Clin Sci (Lond) 1997, 93(6):519-525.
38. Egashira K., Inou T., Hirooka Y., et al. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 1993, 88(1):77-81.
39. Palmer R.M., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988, 333(6174):664-666.
40. Andros E., Detmar-Hanna D., Suteparuk S., et al. The effect of aging on the pharmacokinetics and pharmacodynamics of prazosin. Eur J Clin Pharmacol 1996, 50(1-2):41-46.
41. Tsujii T. Comparison of prazosin, terazosin and tamsulosin in the treatment of symptomatic benign prostatic hyperplasia: a short-term open, randomized multicenter study. BPH Medical Therapy Study Group. Benign prostatic hyperplasia. Int J Urol 2000, 7(6):199-205.
42. Danta A.P., Jimenez-Altayo F., Villa E. Vascular aging: facts and factors. Front Physiol 2012, 3(325):1-2.
43. Seals D.R., Jablonski K.L., Donato A.J. Aging and vascular endothelial function in humans. Clin Sci (Lond) 2011, 120(9):357-375.
44. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. NEngl J Med 2003, 348(7):593-600.
45. Williamson K., Stringer S.E. Endothelial progenitor cells enter the aging arena. Front Physiol 2012, 3(30):1-7.
46. Cosby K., Partovi K.S., Crawford J.H., et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 2003, 9(12):1498-1505.
47. Kapil V., Milsom A.B., Okorie M., et al. Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension 2010, 56(2):274-281.
48. Larsen F.J., Ekblom B., Sahlin K., et al. Effects of dietary nitrate on blood pressure in healthy volunteers. NEngl J Med 2006, 355(26):2792-2793.
49. Webb A.J., Patel N., Loukogeorgakis S., et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 2008, 51(3):784-790.
50. Antoniades C., Bakogiannis C., Leeson P., et al. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. Circulation 2011, 124(3):335-345.
51. Foody J.M., Rathore S.S., Galusha D., et al. Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction. JAm Geriatr Soc 2006, 54(3):421-430.
52. Gransbo K., Melander O., Wallentin L., et al. Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment. JAm Coll Cardiol 2010, 55(13):1362-1369.
53. Shepherd J., Blauw G.J., Murphy M.B., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002, 360(9346):1623-1630.
54. Novella S., Dantas A.P., Segarra G., et al. Vascular aging in women: is estrogen the fountain of youth?. Front Physiol 2012, 3(165):1-8.
55. Lopes R.A., Neves K.B., Carneiro F.S., et al. Testosterone and vascular function in aging. Front Physiol 2012, 3(89):1-9.
56. Thum T., Hoeber S., Froese S., et al. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res 2007, 100(3):434-443.
57. Ming X.F., Montani J.P., Yang Z. Perspectives of targeting mTORC1-S6K1 in cardiovascular aging. Front Physiol 2012, 3(5):1-11.
58. Ungvari Z., Kaley G., de Cabo R., et al. Mechanisms of vascular aging: new perspectives. JGerontol A Biol Sci Med Sci 2010, 65(10):1028-1041.